Test methods to identify and determine nitrosamine impurities in medicines
We have developed the below test methods for the identification and determination of nitrosamine impurities in medicines. These test methods can be adapted and used by you to detect nitrosamine impurities in your products. The methods should be validated by you prior to its use to ensure they are suitable for your intended use. The methods may be subject to revisions if new information becomes available.
Regulatory overview
Register your product
Apply for post-approval variation
Reclassify your product
Dealer's licensing and certification
Retain, cancel or transfer product registration
Risk management plan requirements
Report adverse events
Report or recall defective products
Retail pharmacy licensing
Clinical trials
Product consultation
Advertisements and promotions
CPP and SLS
International collaboration
Medicines quality and compliance monitoring
Listing of approvals and post-registration actions
Guidance documents
Fees and turnaround time
PRISM (Therapeutic products)
Infosearch